ÂÜÀòÂÒÂ×

Richard Blackburn joined Azurity Pharmaceuticals in February 2022 as Chief Executive Officer. Richard is passionate about bringing new medicines to patients with underserved needs and has built and shaped country, regional and global teams throughout his more than 30-year career. Prior to joining Azurity, Richard was Global President for Inflammation and Immunology at Pfizer and led Pfizer business units with responsibilities across the United States, Europe, Africa, the Middle-East, Japan, Australia and New Zealand. He has served as Country Manager for Pfizer in the UK, led International Public Affairs and built and managed Pfizer’s first Global Health & Value platform consolidating the company’s market access, health economics and outcomes research capabilities. Earlier in his career, he had tenures at Sterling-Winthrop, Sanofi and Parke-Davis & Co. where he led successful sales and marketing campaigns across multiple therapeutic areas.

Richard holds a BS in Natural Sciences from Durham University in the UK.